fda semaglutide compounding warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Drug compounders sue FDA over

Members completed more than 10 actions a week on average

People tracking their semaglutide dosing should note GI symptoms at each level to identify their personal threshold

Importantly, we also demonstrate that GLP-1 and its derivatives directly antagonize TRPV1 channels in a mode-selective manner that can offer pain relief without the adverse thermoregulatory side effects commonly associated with current TRPV1 inhibitors

[cited 2026 Jun 23]

At this time, Ozempic has not been approved for use as a weight-loss medication

Certificate of Analysis & Safety Data Frequently Asked Questions Is IPAMORELIN third-party tested